Brokers Set Expectations for Immunovant, Inc.'s FY2028 Earnings (NASDAQ:IMVT)

Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Equities research analysts at HC Wainwright raised their FY2028 earnings per share estimates for shares of Immunovant in a research note issued to investors on Tuesday, February 13th. HC Wainwright analyst D. Tsao now expects that the company will post earnings per share of $2.16 for the year, […]

Related Keywords

United States ,America ,Peter Salzmann ,Piper Sandler ,Marks Levine ,Nasdaq ,Nuveen Asset Management ,Wolfe Research ,Weiss Multi Strategy Advisers ,Blue Owl Capital Holdings ,Immunovant Company Profile ,Securities Exchange Commission ,Immunovant Inc ,Cantor Fitzgerald ,Deutsche Bank Aktiengesellschaft ,Free Report ,Bank Aktiengesellschaft ,Get Free Report ,Owl Capital Holdings ,Capital Investment Management ,Multi Strategy Advisers ,Asset Management ,Octagon Capital Advisors ,Capital Advisors ,Exchange Commission ,Immunovant Daily ,Immunovant ,Nasdaq Imvt ,Imvt ,Medical ,Earnings Estimates ,Hc Wainwright ,